Literature DB >> 19004801

Ataxia with loss of Purkinje cells in a mouse model for Refsum disease.

Sacha Ferdinandusse1, Anna W M Zomer, Jasper C Komen, Christina E van den Brink, Melissa Thanos, Frank P T Hamers, Ronald J A Wanders, Paul T van der Saag, Bwee Tien Poll-The, Pedro Brites.   

Abstract

Refsum disease is caused by a deficiency of phytanoyl-CoA hydroxylase (PHYH), the first enzyme of the peroxisomal alpha-oxidation system, resulting in the accumulation of the branched-chain fatty acid phytanic acid. The main clinical symptoms are polyneuropathy, cerebellar ataxia, and retinitis pigmentosa. To study the pathogenesis of Refsum disease, we generated and characterized a Phyh knockout mouse. We studied the pathological effects of phytanic acid accumulation in Phyh(-/-) mice fed a diet supplemented with phytol, the precursor of phytanic acid. Phytanic acid accumulation caused a reduction in body weight, hepatic steatosis, and testicular atrophy with loss of spermatogonia. Phenotype assessment using the SHIRPA protocol and subsequent automated gait analysis using the CatWalk system revealed unsteady gait with strongly reduced paw print area for both fore- and hindpaws and reduced base of support for the hindpaws. Histochemical analyses in the CNS showed astrocytosis and up-regulation of calcium-binding proteins. In addition, a loss of Purkinje cells in the cerebellum was observed. No demyelination was present in the CNS. Motor nerve conduction velocity measurements revealed a peripheral neuropathy. Our results show that, in the mouse, high phytanic acid levels cause a peripheral neuropathy and ataxia with loss of Purkinje cells. These findings provide important insights in the pathophysiology of Refsum disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004801      PMCID: PMC2584743          DOI: 10.1073/pnas.0806066105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Refsum's disease.

Authors:  A J Wills; N J Manning; M M Reilly
Journal:  QJM       Date:  2001-08

2.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment.

Authors:  D C Rogers; E M Fisher; S D Brown; J Peters; A J Hunter; J E Martin
Journal:  Mamm Genome       Date:  1997-10       Impact factor: 2.957

3.  Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.

Authors:  J M Peters; N Hennuyer; B Staels; J C Fruchart; C Fievet; F J Gonzalez; J Auwerx
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

4.  Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis.

Authors:  L Eldjarn; K Try; O Stokke; A W Munthe-Kaas; S Refsum; D Steinberg; J Avigan; C Mize
Journal:  Lancet       Date:  1966-03-26       Impact factor: 79.321

5.  Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts.

Authors:  G Dacremont; G Vincent
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease.

Authors:  Anthony S Wierzbicki; Phillip D Mayne; Matthew D Lloyd; David Burston; Guam Mei; Margaret C Sidey; Michael D Feher; F Brian Gibberd
Journal:  J Lipid Res       Date:  2003-04-16       Impact factor: 5.922

7.  Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha.

Authors:  A W Zomer; B van Der Burg; G A Jansen; R J Wanders; B T Poll-The; P T van Der Saag
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

8.  Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes.

Authors:  Manuel Heim; James Johnson; Franziska Boess; Igor Bendik; Peter Weber; Willi Hunziker; Beat Fluhmann
Journal:  FASEB J       Date:  2002-03-26       Impact factor: 5.191

Review 9.  Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.

Authors:  Anthony S Wierzbicki; Matthew D Lloyd; Christopher J Schofield; Michael D Feher; F Brian Gibberd
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

Review 10.  Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7).

Authors:  Gerbert A Jansen; Hans R Waterham; Ronald J A Wanders
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

View more
  30 in total

1.  Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination.

Authors:  Tiago Ferreira da Silva; Jessica Eira; André T Lopes; Ana R Malheiro; Vera Sousa; Adrienne Luoma; Robin L Avila; Ronald J A Wanders; Wilhelm W Just; Daniel A Kirschner; Mónica M Sousa; Pedro Brites
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 2.  Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases.

Authors:  Rachayeeta Deb; Neha Joshi; Shirisha Nagotu
Journal:  Neurotox Res       Date:  2021-01-05       Impact factor: 3.911

3.  Neurochemical evidence that pristanic acid impairs energy production and inhibits synaptic Na(+), K(+)-ATPase activity in brain of young rats.

Authors:  Estela Natacha Brandt Busanello; Carolina Maso Viegas; Anelise Miotti Tonin; Mateus Grings; Alana Pimentel Moura; Anderson Büker de Oliveira; Paula Eichler; Moacir Wajner
Journal:  Neurochem Res       Date:  2011-03-29       Impact factor: 3.996

4.  Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6.

Authors:  Toshinori Unno; Minoru Wakamori; Masato Koike; Yasuo Uchiyama; Kinya Ishikawa; Hisahiko Kubota; Takashi Yoshida; Hiroko Sasakawa; Christoph Peters; Hidehiro Mizusawa; Kei Watase
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-10       Impact factor: 11.205

5.  Chronic Hyponatremia Causes Neurologic and Psychologic Impairments.

Authors:  Haruki Fujisawa; Yoshihisa Sugimura; Hiroshi Takagi; Hiroyuki Mizoguchi; Hideyuki Takeuchi; Hisakazu Izumida; Kohtaro Nakashima; Hiroshi Ochiai; Seiji Takeuchi; Atsushi Kiyota; Kazuya Fukumoto; Shintaro Iwama; Yoshiko Takagishi; Yoshitaka Hayashi; Hiroshi Arima; Yukio Komatsu; Yoshiharu Murata; Yutaka Oiso
Journal:  J Am Soc Nephrol       Date:  2015-09-16       Impact factor: 10.121

6.  Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.

Authors:  Mario Manto; Daniele Marmolino
Journal:  Cerebellum       Date:  2009-09       Impact factor: 3.847

Review 7.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

9.  Marked inhibition of Na+, K(+)- ATPase activity and the respiratory chain by phytanic acid in cerebellum from young rats: possible underlying mechanisms of cerebellar ataxia in Refsum disease.

Authors:  Estela Natacha Brandt Busanello; Ângela Zanatta; Anelise Miotti Tonin; Carolina Maso Viegas; Carmen Regla Vargas; Guilhian Leipnitz; César Augusto João Ribeiro; Moacir Wajner
Journal:  J Bioenerg Biomembr       Date:  2012-11-15       Impact factor: 2.945

10.  A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.

Authors:  Nancy Braverman; Rui Zhang; Li Chen; Graeme Nimmo; Sarah Scheper; Tammy Tran; Rupsa Chaudhury; Ann Moser; Steven Steinberg
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.